Cargando…

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

Monoclonal gammopathies (MG) constitute a spectrum of disorders starting from a monoclonal gammopathy of undetermined significance (MGUS) to active disease requiring therapy such as multiple myeloma. MG are characterized by proliferation of clonal plasma cells (PC) secreting a monoclonal protein eit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Shaji, Larson, Dirk R., Dispenzieri, Angela, Therneau, Terry M., Murray, David L., Leif Bergsagel, P., Kyle, Robert A., Vincent Rajkumar, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525262/ https://www.ncbi.nlm.nih.gov/pubmed/31101803 http://dx.doi.org/10.1038/s41408-019-0210-z

Ejemplares similares

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry
por: Baughn, Linda B., et al.
Publicado: (2018)

Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
por: Murray, David, et al.
Publicado: (2019)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021)

Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
por: Ryu, Alexander J., et al.
Publicado: (2023)

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022)

Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy
por: Zanwar, Saurabh, et al.
Publicado: (2022)

Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
por: Willrich, Maria Alice V., et al.
Publicado: (2022)

Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)

Cutaneous manifestations of monoclonal gammopathy
por: Claveau, Jean-Sebastien, et al.
Publicado: (2022)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy
por: Kim, Han-Sung, et al.
Publicado: (2014)

Crystal‐storing histiocytosis associated with monoclonal kappa light chain gammopathy
por: Lesesve, Jean‐François, et al.
Publicado: (2022)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
por: Chauvet, Sophie, et al.
Publicado: (2018)

The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure
por: Cirit, Mustafa, et al.
Publicado: (2012)

Comment on “Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy”
por: Parker, Antony R., et al.
Publicado: (2015)

N-Glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
por: Dispenzieri, Angela, et al.
Publicado: (2020)

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey
por: Landgren, O, et al.
Publicado: (2017)

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies
por: Cigliana, Giovanni, et al.
Publicado: (2015)

Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
por: Gran, Charlotte, et al.
Publicado: (2020)

Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010)

Polyclonal Immunotactoid Glomerulopathy Associated with Monoclonal Gammopathy of IgM Type and Underlying Plasmacellular Disease: Successful Treatment with Rituximab Alone
por: Neukirchen, Wolfgang, et al.
Publicado: (2022)

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia
por: Gutiérrez-Peredo, Gabriel Brayan, et al.
Publicado: (2022)

Polyclonal light chains in cerebrovascular disease
por: Fiori, Patrizia, et al.
Publicado: (2010)

Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)

Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?
por: Kapoor, Prashant, et al.
Publicado: (2022)

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination
por: Zanwar, Saurabh, et al.
Publicado: (2022)

Helicobacter pylori Infection and Light Chain Gammopathy
por: Girón, José A., et al.
Publicado: (2013)

An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases
por: Bettacchioli, Eléonore, et al.
Publicado: (2021)

Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review
por: Yu, Xiao-juan, et al.
Publicado: (2018)

Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023)

Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond
por: Abeykoon, Jithma P, et al.
Publicado: (2022)

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma
por: Greenberg, Alexandra J., et al.
Publicado: (2013)

Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?
por: Brebner, Judith A., et al.
Publicado: (2013)

Polyclonal gammopathy related to renal bleeding in a peritoneal dialysis patient
por: Cho, Eun-Mi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aqd5m2olfa2b11lgb1jpq2pdu9